Devine Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -27.21%
- Profit Growth -14.05%
- Ebitda 93.24%
- Net Worth 41.42%
- Total Assets -4.58%
About Devine Meditech
Devine Meditech Private Limited (DMPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 2012 and has a history of 12 years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vipin Agrawal and Deepti Agrawal serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33110DL2012PTC239484
-
Company No.
239484
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jul 2012
-
Date of AGM
23 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Devine Meditech Private Limited offer?
Devine Meditech Private Limited offers a wide range of products and services, including Abrasives & Grains, Abrasive Wheels, Jewellery Making Tools & Machines, Diamond Processing Machinery.
Who are the key members and board of directors at Devine Meditech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipin Agrawal
|
Director | 28-Jul-2012 | Current |
|
Deepti Agrawal
|
Director | 31-Aug-2017 | Current |
Financial Performance of Devine Meditech.
Devine Meditech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 27.21% decrease. The company also saw a substantial fall in profitability, with a 14.05% decrease in profit. The company's net worth Soared by an impressive increase of 41.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Devine Meditech?
In 2021, Devine Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Devine Ocular Devices Private LimitedVipin Agrawal and Deepti Agrawal are mutual person
-
Lensvision Technology Private LimitedVipin Agrawal and Deepti Agrawal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Devine Meditech?
Unlock and access historical data on people associated with Devine Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Devine Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devine Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
